Eventide Asset Management - Q4 2023 holdings

$6.13 Billion is the total value of Eventide Asset Management's 152 reported holdings in Q4 2023. The portfolio turnover from Q3 2023 to Q4 2023 was 29.0% .

 Value Shares↓ Weighting
XMTR BuyXOMETRY INC$204,340,289
+176.1%
5,690,345
+30.5%
3.34%
+150.8%
TT BuyTRANE TECHNOLOGIES PLC$195,061,708
+21.6%
799,761
+1.2%
3.18%
+10.4%
ZNTL BuyZENTALIS PHARMACEUTICALS INC$175,133,621
+11.7%
11,559,975
+47.9%
2.86%
+1.5%
ODFL SellOLD DOMINION FREIGHT LINE IN$170,811,331
-6.0%
421,413
-5.1%
2.79%
-14.6%
CLDX BuyCELLDEX THERAPEUTICS INC NEW$143,966,316
+227.0%
3,630,013
+126.9%
2.35%
+197.1%
ROP SellROPER TECHNOLOGIES INC$128,939,792
+12.3%
236,513
-0.3%
2.10%
+2.0%
CRWD BuyCROWDSTRIKE HLDGS INCcl a$127,513,191
+52.5%
499,425
+0.0%
2.08%
+38.5%
IDXX SellIDEXX LABS INC$124,316,214
+26.9%
223,973
-0.0%
2.03%
+15.2%
PANW SellPALO ALTO NETWORKS INC$123,408,165
-1.2%
418,503
-21.5%
2.01%
-10.3%
WCN BuyWASTE CONNECTIONS INC$120,911,984
+11.9%
810,022
+0.7%
1.97%
+1.6%
DHI BuyD R HORTON INC$118,657,777
+47.0%
780,746
+3.9%
1.94%
+33.5%
POOL SellPOOL CORP$114,069,336
+11.6%
286,096
-0.3%
1.86%
+1.4%
GH BuyGUARDANT HEALTH INC$105,174,349
-1.1%
3,888,146
+8.3%
1.72%
-10.2%
GLBE BuyGLOBAL E ONLINE LTD$97,656,127
+0.3%
2,464,197
+0.5%
1.59%
-9.0%
FLYW BuyFLYWIRE CORPORATION$97,305,562
-25.1%
4,203,264
+3.2%
1.59%
-31.9%
DDOG BuyDATADOG INC$96,803,099
+45.4%
797,521
+9.1%
1.58%
+32.0%
SWAV BuySHOCKWAVE MED INC$96,465,283
+36.2%
506,220
+42.3%
1.58%
+23.7%
DLO SellDLOCAL LTD$95,925,139
-8.6%
5,422,563
-0.9%
1.57%
-16.9%
ARGX SellARGENX SEsponsored adr$93,498,662
-40.8%
245,771
-23.5%
1.53%
-46.3%
LAD BuyLITHIA MTRS INC$88,206,539
+20.7%
267,877
+8.2%
1.44%
+9.6%
MTD SellMETTLER TOLEDO INTERNATIONAL$87,724,906
-27.0%
72,323
-33.3%
1.43%
-33.7%
EVH BuyEVOLENT HEALTH INCcl a$87,164,386
+21.3%
2,638,946
+0.0%
1.42%
+10.1%
HUBS BuyHUBSPOT INC$81,994,889
+18.8%
141,239
+0.8%
1.34%
+7.9%
COLL SellCOLLEGIUM PHARMACEUTICAL INC$80,966,113
+37.7%
2,630,478
-0.0%
1.32%
+25.1%
LOW SellLOWES COS INC$80,802,564
-12.9%
363,076
-18.7%
1.32%
-20.9%
EXAS SellEXACT SCIENCES CORP$80,143,496
-37.1%
1,083,313
-42.0%
1.31%
-42.9%
MIRM SellMIRUM PHARMACEUTICALS INC$78,630,919
-37.1%
2,663,649
-32.7%
1.28%
-42.9%
TMDX BuyTRANSMEDICS GROUP INC$78,475,363
+54.9%
994,240
+7.4%
1.28%
+40.6%
MNDY BuyMONDAY COM LTD$76,602,065
+136.3%
407,870
+100.3%
1.25%
+114.4%
COUR BuyCOURSERA INC$76,275,263
+10.5%
3,937,804
+6.6%
1.24%
+0.3%
TTD BuyTHE TRADE DESK INC$74,182,772
-6.3%
1,030,889
+1.8%
1.21%
-14.8%
TREX BuyTREX CO INC$73,069,461
+34.3%
882,588
+0.0%
1.19%
+22.0%
DV BuyDOUBLEVERIFY HLDGS INC$70,637,424
+31.6%
1,920,539
+0.0%
1.15%
+19.5%
APTV BuyAPTIV PLC$70,472,638
-8.9%
785,473
+0.1%
1.15%
-17.3%
LRCX SellLAM RESEARCH CORP$67,007,110
-7.8%
85,549
-26.2%
1.09%
-16.2%
BuyTOAST INCcl a$66,650,205
+21.6%
3,650,066
+24.7%
1.09%
+10.5%
ENTG BuyENTEGRIS INC$64,340,584
+35.0%
536,977
+5.8%
1.05%
+22.5%
MPWR BuyMONOLITHIC PWR SYS INC$62,026,490
+36.5%
98,333
+0.0%
1.01%
+24.0%
KRTX SellKARUNA THERAPEUTICS INC$60,136,900
+4.7%
190,000
-44.1%
0.98%
-4.9%
FIVN BuyFIVE9 INC$55,362,428
+24.1%
703,551
+1.4%
0.90%
+12.7%
ASML SellASML HOLDING N V$52,869,348
+28.5%
69,848
-0.1%
0.86%
+16.8%
LNG BuyCHENIERE ENERGY INC$51,421,778
+2.9%
301,223
+0.0%
0.84%
-6.6%
BuyAURA BIOSCIENCES INC$51,411,763
+89.5%
5,802,682
+91.8%
0.84%
+71.9%
 MARINUS PHARMACEUTICALS INC$49,241,067
+35.0%
4,529,9970.0%0.80%
+22.7%
CYTK  CYTOKINETICS INC$46,420,440
+183.4%
556,0000.0%0.76%
+157.8%
NVT SellNVENT ELECTRIC PLC$45,445,942
+8.8%
769,097
-2.4%
0.74%
-1.1%
KLAC BuyKLA CORP$45,396,624
+47.6%
78,095
+16.5%
0.74%
+34.0%
BILL BuyBILL HOLDINGS INC$42,680,953
+114.6%
523,115
+185.5%
0.70%
+94.7%
ARDX BuyARDELYX INC$42,194,063
+283.7%
6,805,494
+152.5%
0.69%
+248.0%
TRGP SellTARGA RES CORP$41,494,498
-15.8%
477,662
-16.9%
0.68%
-23.5%
CDW BuyCDW CORP$41,035,806
+20.6%
180,520
+7.0%
0.67%
+9.5%
DVAX BuyDYNAVAX TECHNOLOGIES CORP$40,450,221
+92.2%
2,893,435
+103.0%
0.66%
+74.6%
NewLEXEO THERAPEUTICS INC$40,297,9923,002,831
+100.0%
0.66%
LSCC BuyLATTICE SEMICONDUCTOR CORP$38,312,148
+4.2%
555,329
+29.7%
0.62%
-5.4%
PCVX BuyVAXCYTE INC$38,132,537
+90.3%
607,206
+54.5%
0.62%
+72.8%
CRNX BuyCRINETICS PHARMACEUTICALS IN$37,701,742
+24.4%
1,059,633
+4.0%
0.62%
+12.8%
SPT SellSPROUT SOCIAL INC$36,049,244
-26.9%
586,739
-40.7%
0.59%
-33.7%
NARI  INARI MED INC$33,298,377
-0.7%
512,9140.0%0.54%
-9.8%
FERG BuyFERGUSON PLC NEW$32,891,791
+37.0%
170,362
+16.7%
0.54%
+24.3%
ORLY BuyOREILLY AUTOMOTIVE INC$29,554,139
+5.8%
31,107
+1.2%
0.48%
-4.0%
SHW BuySHERWIN WILLIAMS CO$29,419,032
+23.9%
94,322
+1.3%
0.48%
+12.4%
SNPS SellSYNOPSYS INC$29,005,910
-20.0%
56,332
-28.7%
0.47%
-27.5%
BBIO  BRIDGEBIO PHARMA INC$28,942,343
+53.1%
716,9270.0%0.47%
+38.8%
BPMC SellBLUEPRINT MEDICINES CORP$28,813,378
+30.8%
312,374
-28.8%
0.47%
+18.7%
AJG BuyGALLAGHER ARTHUR J & CO$28,376,708
+14.7%
126,186
+16.2%
0.46%
+4.0%
WMB BuyWILLIAMS COS INC$27,739,065
+4.7%
796,413
+1.3%
0.45%
-4.8%
AXSM  AXSOME THERAPEUTICS INC$27,594,808
+13.9%
346,7120.0%0.45%
+3.2%
VRNA BuyVERONA PHARMA PLCsponsored ads$27,390,286
+97.7%
1,377,781
+62.1%
0.45%
+79.5%
NewKORRO BIO INC$26,185,357546,325
+100.0%
0.43%
WDAY BuyWORKDAY INCcl a$26,077,732
+29.9%
94,464
+1.1%
0.43%
+18.0%
ISRG BuyINTUITIVE SURGICAL INC$25,873,488
+15.9%
76,694
+0.4%
0.42%
+5.2%
PNR BuyPENTAIR PLC$25,749,592
+20.4%
354,141
+7.2%
0.42%
+9.4%
IRTC  IRHYTHM TECHNOLOGIES INC$25,597,010
+13.6%
239,1350.0%0.42%
+3.2%
INSP  INSPIRE MED SYS INC$25,447,059
+2.5%
125,0900.0%0.42%
-7.0%
ACAD NewACADIA PHARMACEUTICALS INC$25,342,032809,391
+100.0%
0.41%
EGP BuyEASTGROUP PPTYS INC$25,334,026
+128.9%
138,030
+107.7%
0.41%
+108.0%
PRVA  PRIVIA HEALTH GROUP INC$23,030,000
+0.1%
1,000,0000.0%0.38%
-9.0%
KROS  KEROS THERAPEUTICS INC$23,060,800
+24.7%
580,0000.0%0.38%
+13.3%
ASND SellASCENDIS PHARMA A/Ssponsored adr$22,778,939
-57.7%
180,857
-68.6%
0.37%
-61.6%
IMGN SellIMMUNOGEN INC$22,622,950
+9.7%
763,000
-41.3%
0.37%
-0.5%
STE SellSTERIS PLC$21,737,229
-2.4%
98,873
-2.6%
0.36%
-11.2%
MDB BuyMONGODB INCcl a$21,666,597
+759.2%
52,994
+626.8%
0.35%
+686.7%
ROL BuyROLLINS INC$21,412,711
+17.0%
490,330
+0.0%
0.35%
+6.4%
RGEN  REPLIGEN CORP$21,396,200
+13.1%
119,0000.0%0.35%
+2.6%
ALV BuyAUTOLIV INC$21,366,502
+2520.8%
193,906
+2194.7%
0.35%
+2226.7%
NOVT SellNOVANTA INC$21,223,028
+17.4%
126,020
-0.0%
0.35%
+6.5%
HLI BuyHOULIHAN LOKEY INCcl a$21,016,506
+31.1%
175,269
+17.1%
0.34%
+19.1%
CERE  CEREVEL THERAPEUTICS HLDNG I$20,776,000
+94.2%
490,0000.0%0.34%
+76.6%
INSM  INSMED INC$19,684,383
+22.7%
635,1850.0%0.32%
+11.5%
SRRK NewSCHOLAR ROCK HLDG CORP$18,287,380972,733
+100.0%
0.30%
ESI BuyELEMENT SOLUTIONS INC$18,103,001
+35.0%
782,325
+14.4%
0.30%
+22.4%
RARE  ULTRAGENYX PHARMACEUTICAL IN$17,167,380
+34.1%
359,0000.0%0.28%
+21.7%
NewBIOHAVEN LTD$17,167,123401,101
+100.0%
0.28%
FANG SellDIAMONDBACK ENERGY INC$17,000,025
-35.3%
109,621
-35.4%
0.28%
-41.3%
KRYS NewKRYSTAL BIOTECH INC$16,932,329136,485
+100.0%
0.28%
ALNY NewALNYLAM PHARMACEUTICALS INC$16,652,67087,000
+100.0%
0.27%
MSCI SellMSCI INC$16,417,426
+8.0%
29,024
-2.0%
0.27%
-1.8%
 AMYLYX PHARMACEUTICALS INC$16,439,841
-19.6%
1,116,8370.0%0.27%
-27.2%
CMS SellCMS ENERGY CORP$16,206,176
-7.9%
279,080
-15.8%
0.26%
-16.1%
PRTA  PROTHENA CORP PLC$16,176,933
-24.7%
445,1550.0%0.26%
-31.6%
MASS  908 DEVICES INC$16,055,764
+68.5%
1,430,9950.0%0.26%
+53.2%
VCYT SellVERACYTE INC$15,515,640
-5.1%
564,000
-23.0%
0.25%
-13.9%
BRKR  BRUKER CORP$15,457,620
+17.9%
210,3650.0%0.25%
+6.8%
RPRX SellROYALTY PHARMA PLC$14,999,358
-45.0%
533,975
-46.8%
0.24%
-50.0%
RCKT SellROCKET PHARMACEUTICALS INC$14,707,238
-20.1%
490,732
-45.4%
0.24%
-27.5%
BuyR1 RCM INC$14,544,109
+31.2%
1,375,980
+87.0%
0.24%
+19.1%
VKTX  VIKING THERAPEUTICS INC$13,957,500
+68.1%
750,0000.0%0.23%
+53.0%
INZY BuyINOZYME PHARMA INC$13,546,106
+3.2%
3,179,837
+1.8%
0.22%
-6.4%
SellGXO LOGISTICS INCORPORATED$13,465,597
+4.3%
220,170
-0.0%
0.22%
-5.2%
COGT BuyCOGENT BIOSCIENCES INC$13,129,852
-37.4%
2,232,968
+3.9%
0.21%
-43.2%
SellROIVANT SCIENCES LTD$12,846,424
-34.9%
1,143,938
-32.3%
0.21%
-40.8%
APLS NewAPELLIS PHARMACEUTICALS INC$12,558,269209,794
+100.0%
0.20%
IDYA  IDEAYA BIOSCIENCES INC$11,919,300
+31.9%
335,0000.0%0.20%
+20.4%
IEX SellIDEX CORP$11,863,542
-2.2%
54,643
-6.3%
0.19%
-11.0%
SO NewSOUTHERN CO$11,850,631169,005
+100.0%
0.19%
NTLA  INTELLIA THERAPEUTICS INC$11,362,556
-3.6%
372,6650.0%0.18%
-12.7%
VST BuyVISTRA CORP$11,282,778
+200.6%
292,907
+158.9%
0.18%
+174.6%
VRSK BuyVERISK ANALYTICS INC$11,120,127
+24.3%
46,555
+22.9%
0.18%
+13.0%
RVMD  REVOLUTION MEDICINES INC$10,353,480
+3.6%
361,0000.0%0.17%
-6.1%
EHC SellENCOMPASS HEALTH CORP$10,117,688
-11.4%
151,644
-10.9%
0.16%
-19.5%
ARWR NewARROWHEAD PHARMACEUTICALS IN$9,586,643313,289
+100.0%
0.16%
ANAB  ANAPTYSBIO INC$9,146,340
+19.3%
427,0000.0%0.15%
+8.0%
SYY SellSYSCO CORP$8,793,809
-1.3%
120,249
-10.9%
0.14%
-10.0%
GPI BuyGROUP 1 AUTOMOTIVE INC$8,666,196
+87.2%
28,438
+65.0%
0.14%
+69.9%
SRPT SellSAREPTA THERAPEUTICS INC$8,603,388
-42.1%
89,219
-27.3%
0.14%
-47.6%
IRWD NewIRONWOOD PHARMACEUTICALS INC$8,471,938740,554
+100.0%
0.14%
SRE NewSEMPRA$8,395,168112,340
+100.0%
0.14%
INCY NewINCYTE CORP$7,629,487121,508
+100.0%
0.12%
EQIX SellEQUINIX INC$7,673,756
-0.4%
9,528
-10.2%
0.12%
-9.4%
TGTX NewTG THERAPEUTICS INC$7,506,216439,474
+100.0%
0.12%
BEAM  BEAM THERAPEUTICS INC$7,114,219
+13.2%
261,3600.0%0.12%
+2.7%
PNFP NewPINNACLE FINL PARTNERS INC$7,050,95280,841
+100.0%
0.12%
CBT NewCABOT CORP$6,918,89482,861
+100.0%
0.11%
RCUS  ARCUS BIOSCIENCES INC$4,584,000
+6.4%
240,0000.0%0.08%
-2.6%
PCOR NewPROCORE TECHNOLOGIES INC$3,301,93247,702
+100.0%
0.05%
NewVYNE THERAPEUTICS INC$3,248,8031,394,336
+100.0%
0.05%
INTA BuyINTAPP INC$3,271,089
+13.5%
86,036
+0.1%
0.05%
+1.9%
 ARTERIS INC$2,350,245
-9.5%
399,0230.0%0.04%
-19.1%
 XOMETRY INCnote 1.000% 2/0$1,983,447
+29.6%
2,100,0000.0%0.03%
+14.3%
BuyLINDE PLC$1,878,588
+174.3%
4,574
+148.7%
0.03%
+158.3%
SPGI BuyS&P GLOBAL INC$1,853,708
+123.0%
4,208
+85.0%
0.03%
+100.0%
 TURNSTONE BIOLOGICS CORP$1,802,667
-35.4%
708,3170.0%0.03%
-42.0%
NOW BuySERVICENOW INC$1,396,731
+72.2%
1,977
+36.3%
0.02%
+53.3%
INTU NewINTUIT$1,233,8091,974
+100.0%
0.02%
SNV NewSYNOVUS FINL CORP$968,13225,714
+100.0%
0.02%
TSM BuyTAIWAN SEMICONDUCTOR MFG LTDsponsored ads$912,600
+53.3%
8,775
+28.1%
0.02%
+36.4%
NVDA BuyNVIDIA CORPORATION$773,534
+55.2%
1,562
+36.3%
0.01%
+44.4%
SHOP SellSHOPIFY INCcl a$697,283
-4.4%
8,951
-33.1%
0.01%
-15.4%
ZTS BuyZOETIS INCcl a$622,308
+60.0%
3,153
+41.0%
0.01%
+42.9%
EW SellEDWARDS LIFESCIENCES CORP$511,561
-24.6%
6,709
-31.5%
0.01%
-33.3%
ALGN SellALIGN TECHNOLOGY INC$307,154
-47.7%
1,121
-41.8%
0.01%
-54.5%
AVTE NewAEROVATE THERAPEUTICS INC$275,58812,178
+100.0%
0.00%
COMP ExitCOMPASS INCcl a$0-111,613
-100.0%
-0.01%
WM ExitWASTE MGMT INC DEL$0-3,173
-100.0%
-0.01%
PXD ExitPIONEER NAT RES CO$0-6,938
-100.0%
-0.03%
PTGX ExitPROTAGONIST THERAPEUTICS INC$0-320,000
-100.0%
-0.10%
ELS ExitEQUITY LIFESTYLE PPTYS INC$0-109,455
-100.0%
-0.12%
INBX ExitINHIBRX INC$0-434,026
-100.0%
-0.14%
PLD ExitPROLOGIS INC.$0-79,455
-100.0%
-0.16%
FREQ ExitFREQUENCY THERAPEUTICS INC$0-3,597,122
-100.0%
-0.18%
EQT ExitEQT CORP$0-316,200
-100.0%
-0.23%
DNLI ExitDENALI THERAPEUTICS INC$0-621,850
-100.0%
-0.23%
BCRX ExitBIOCRYST PHARMACEUTICALS INC$0-1,970,000
-100.0%
-0.25%
XENE ExitXENON PHARMACEUTICALS INC$0-413,906
-100.0%
-0.25%
BMRN ExitBIOMARIN PHARMACEUTICAL INC$0-164,299
-100.0%
-0.26%
NBIX ExitNEUROCRINE BIOSCIENCES INC$0-135,000
-100.0%
-0.27%
RPHM ExitRENEO PHARMACEUTICALS INC$0-2,078,142
-100.0%
-0.28%
NEP ExitNEXTERA ENERGY PARTNERS LP$0-588,359
-100.0%
-0.31%
BEPC ExitBROOKFIELD RENEWABLE CORPcl a sub vtg$0-776,152
-100.0%
-0.33%
AKRO ExitAKERO THERAPEUTICS INC$0-513,876
-100.0%
-0.47%
MRTX ExitMIRATI THERAPEUTICS INC$0-600,000
-100.0%
-0.47%
BEP ExitBROOKFIELD RENEWABLE PARTNERpartnership unit$0-1,236,000
-100.0%
-0.48%
SGEN ExitSEAGEN INC$0-130,990
-100.0%
-0.50%
HASI ExitHANNON ARMSTRONG SUST INFR C$0-1,378,294
-100.0%
-0.52%
SHLS ExitSHOALS TECHNOLOGIES GROUP INcl a$0-2,332,576
-100.0%
-0.76%
HZNP ExitHORIZON THERAPEUTICS PUB L$0-689,732
-100.0%
-1.43%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2024-02-20
Signatures

The EDGAR filing(s) were signed by:

About Eventide Asset Management

Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.

The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.

The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.

Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.

Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LOWES COS INC43Q2 20243.2%
PALO ALTO NETWORKS INC43Q2 20243.6%
ASML HOLDINGS NV43Q2 20241.9%
REPLIGEN CORP43Q2 20240.5%
VERACYTE INC41Q2 20241.5%
NEUROCRINE BIOSCIENCES INC40Q3 20231.1%
LAM RESEARCH CORP38Q2 20243.4%
COLLEGIUM PHARMACEUTICAL INC37Q2 20242.6%
BLUEPRINT MEDICINES CORP36Q2 20241.3%
XPO LOGISTICS INC34Q1 20233.8%

View Eventide Asset Management's complete holdings history.

Latest significant ownerships (13-D/G)
Eventide Asset Management Q4 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
908 Devices Inc.February 14, 20241,430,9954.4%
Annexon, Inc.Sold outFebruary 14, 202400.0%
Celldex Therapeutics, Inc.February 14, 20243,630,0136.6%
COLLEGIUM PHARMACEUTICAL, INCFebruary 14, 20242,630,4788.1%
Freeline Therapeutics Holdings plcSold outFebruary 14, 202400.0%
Inozyme Pharma, Inc.February 14, 20243,179,8375.2%
Korro Bio, Inc.February 14, 2024546,3256.8%
MARINUS PHARMACEUTICALS, INC.February 14, 20244,529,9978.3%
Mirum Pharmaceuticals, Inc.February 14, 20242,693,5815.8%
Praxis Precision Medicines, Inc.Sold outFebruary 14, 202400.0%

View Eventide Asset Management's complete significant-ownership history.

Latest filings
TypeFiled
N-PX2024-08-27
13F-HR2024-08-13
SC 13G/A2024-08-09
13F-HR2024-05-15
13F-HR/A2024-02-20
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Eventide Asset Management's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export Eventide Asset Management's holdings